Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Change in Cash (2025 - 2026)

Updated

Nervgen Pharma's Change in Cash came in at $50.77 million for Q2 2026, compared with $868,455 a year earlier.

Analysis

Nervgen Pharma (NGEN) Change in Cash (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nervgen Pharma reported Change in Cash of $45.67 million; for FY2025, it was $3.44 million, down 16.1% from FY2024.

  • Going back by year, Change in Cash was $4.1 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.51 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.76 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.04 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 845.00 Mn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 50.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.77 Mn
Mar 31, 2026 -4.02 Mn
Jun 30, 2025 868,455.41
Mar 31, 2025 -1.95 Mn
API Access

Nervgen Pharma Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=NGEN&period=max&api_key=YOUR_API_KEY